SCIENTIFIC PROGRAMME Friday, 9 May 2025
004
Exploring the microbiota-gut-brain axis in ADHD: Gut microbiome associations and therapeutic insights Debora Miranda, Brazil M. Romano-Silva, M. França, A. Alvim Soares Terrorized minds: Exploring the psychosocial impact of terrorism threats on adults with ADHD Rachel Shoham, Israel H. Dayan
PL-01 Plenary Session 08:30 – 10:00
Congress Hall
Translating ADHD research to clinical world Chairs: Stephen Faraone, USA Luis Augusto Rohde, Brazil 001
005
W hat clinicians need to know about ADHD genetics? Stephen Faraone, USA N on-pharmacological treatment for ADHD: What is almost there? Margaret Sibley, USA D igital solutions in the assessment and treat- ment of ADHD: What already helps clinicians? Manfred Döpfner, Germany
002
006
ADHD: From the bottom up Miguel Vizcaíno Da Silva, Spain
R. Blanco Fernández, R. Fernandez, A. Izquierdo Lapuente, P. Del Sol Calderón, A. Perez Balaguer, A. Rodriguez, M. Martin Garcia, O. Mendez Gonzalez, R. Albillos Perez, M. Garcia Moreno C ommon and different gut metagenomic and metabolic profiles linked to diverse ADHD presentations Xinyue Wang, People‘s Republic of China N. Wang, L. Yang
003
007
PL-02 Plenary Session 10:30 – 12:00
Congress Hall
ADHD and trauma across the lifespan Chairs: Mark Bellgrove, Australia Michal Goetz, Czech Republic 001
P-02 Guided Poster Tour 12:45 – 14:45 Genetics Chair: Ditte Demontis, Denmark 001
What should we make of the reported link between ADHD and maltreatment? Edmund Sonuga-Barke, United Kingdom Understanding ADHD in the context of genetic trauma predictors Ditte Demontis, Denmark Trauma recovery for ADHD with adverse childhood experiences - the work of trauma- focused psychotherapy in the perspective of adaptive information processing Jinsong Zhang, People’s Republic of China
Congress Hall Foyer 2B (2 nd Floor)
002
G enotype-phenotype association analysis of sustained attention in adult ADHD and in at- risk population Livia Balogh, Hungary A. Pulay, K. Vincze, Z. Hantos-Horváth, S. Bálint, T. Kilencz, V. Simon, Z. Nemoda, P. Czobor, I. Bitter, J. Réthelyi G enetic overlap between ADHD and migraine Pau Carabi Gassol, Spain M. Ribasés, J. Ramos-Quiroga, V. Macias, S. Alemany, C. Fadeuilhe, M. Corrales, V. Richarte, J. Cabana Domínguez, M. Soler Artigas M onogenic causes and pharmacogenetic thera- pies in ADHD Michele Ciliberto, Italy C. Modafferi, D. Segatori, R. Brugnoli, M. Mazza, G. Sani H igher socioeconomic status uncouples ADHD disease severity from polygenic risk burden in an ADHD population Carsten Drepper, Germany A. Chiocchetti, P. Poursafa, J. Geißler, A. Kaiser, T. Banaschewski, M. Romanos, E. Consortium Cell type-specific methylome-wide association studies of childhood ADHD symptoms Marieke Klein, The Netherlands M. Meijer, D. Caramaschi, S. Clark, B. Franke, W. Copeland, K. Aberg, E. Van Den Oord, P. Pace
003
002
P-01 Guided Poster Tour 12:45 – 14:45 Pathogenesis Chair: Edna Grünblatt, Switzerland 001
Congress Hall Foyer 2B (2 nd Floor)
003
The cerebellum in children and adolescents with ADHD Oliver Bilke-Hentsch, Switzerland I. Charrua, R. Yurchyshyn, D. Schutter ADHD and non-neurological medical comor- bidities: A narrative review Josh Kaplan, USA The role of current psychosocial stressors and post-trauma symptoms on the associa- tion between ADHD symptoms and executive functioning performance Michael Meinzer, USA L. Tufty, J. Harris, J. Soble
004
002
003
005
18
Made with FlippingBook Digital Publishing Software